NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company and a growing global supplier of reagents for a wide range of advanced research applications, announced today that Barry Weiner, President, and David Goldberg, Vice President of Corporate Development, will make a presentation at the Lazard Capital Markets Fifth Annual Healthcare Conference on Tuesday, November 18, 2008, at 3:40 PM (E.T.) at The St. Regis Hotel in New York City.
